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Abstract
Purpose: To analyze the use of this sponge in pediatric patients undergoing split-liver 
transplantation. 
Methods: Retrospective study, including 35 pediatric patients undergoing split-liver 
transplantation, divided into two groups according to the use of the sponge: 18 patients in 
Group A (no sponge) and 17 in Group B (with sponge). 
Results: The characteristics of recipients and donors were similar. We observed greater 
number of reoperation due to bleeding in the wound area in Group A (10 patients - 55.5%) than 
in Group B (3 patients - 17.6%); p = 0.035. The median volume of red blood cells transfused 
in Group A was significantly higher (73.4 ± 102.38 mL/kg) than that in Group B (35.1 ± 41.67 
mL/kg); p = 0.048. Regarding bile leak there was no statistical difference.
Conclusion: The use of the human fibrinogen and thrombin sponge, required lower volume 
of red blood cell transfusion and presented lower reoperation rates due to bleeding in the 
wound area.
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the split technique may be associated with 
complications such as increased bleeding in 
the wound area, greater requirement of red 
blood cell transfusion, and occurrence of biliary 
leak12,16-18.
 The human fibrinogen and thrombin 
sponge (TachoSil®, Takeda, Linz, Austria)19 
is a useful tool in surgical hemostasis that 
consists of a collagen matrix with a layer of 
plasma components such as clotting factors, 
fibrinogen, and fibrin. The use of the sponge 
in liver surgery has been described in large 
studies demonstrating that after hepatectomy 
(surgery in which an open wound is created in 
the liver), the use of the sponge obtained rapid 
and effective hemostasis at the bleeding area 
when compared with other methods20-23.
 The sponge has been used in pediatric 
patients undergoing liver transplantation, in a 
case series in which two children received the 
left segment of the liver from a living donor, 
while two others received a reduced graft. In 
all four cases, the sponge was used in the open 
area of the graft with optimal and effective 
hemostasis24.
 Regarding biliary leak (another possible 
complication in the wound area created during 
the split), the sponge has been studied in adults 
undergoing liver transplantation with the split 
technique, showing that the use of the sponge 
was associated with a lower incidence of biliary 
fistula in the open area of the liver graft18.
 Based on these considerations, the 
objective of this study was to analyze the use 
of the human fibrinogen and thrombin sponge 
in pediatric patients undergoing split-liver 
transplantation.
 ■ Methods
 The project of this study was approved 
by the Ethics Committee at Universidade 
Federal de São Paulo (UNIFESP), number 
38311,18 June 2012. 
 This was a retrospective study 
 ■ Introduction
 Pediatric liver transplantation is 
associated with good results in the literature, 
achieving survival rates at 1 year of more 
than 90%1-5. However, it is difficult to find 
deceased liver donors with suitable grafts for 
small recipients6-8. In addition to the shortage 
of organs for transplantation from deceased 
donors, the mortality of the patients in waiting 
lists is a concerning reality3,9-11.
 Some techniques have been developed 
as surgical alternatives to increase the 
number of viable liver grafts available for 
liver transplantation and reduce the mortality 
rates in liver transplant waiting lists. One such 
technique is split-liver transplantation12-14, 
described by Pichlmayr et al.15. In this 
technique, a liver graft from a cadaver donor 
is divided on an auxiliary table respecting the 
anatomical liver segments while preserving 
their vascular structures, yielding two partial 
grafts suitable for transplantation into two 
distinct recipients. Grafts with liver segments 
II and III are transplanted into pediatric 
recipients, while those with segments I and IV-
VIII are transplanted into adult ones (Figure 1). 
Figure 1 - Hepatic graft with split technique, 
with the formation of two liver grafts suitable for 
transplantation.
 According to the current literature, 
the split technique has good results, with 
survival rates similar to those obtained with 
whole graft transplants6,7,12,16,17. However, 
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conducted from September 2009 to April 2016 
including pediatric patients undergoing split-
liver transplantation at Hospital São Paulo, 
UNIFESP.
 The study included 35 patients divided 
into two groups according to the use of the 
sponge during transplantation: 18 patients 
allocated to Group A (without the sponge) and 
17 to Group B (with the sponge).
 Potential donors for the split-liver 
transplantation were selected when matching 
most of the criteria established by our 
institution, as previously established in the 
literature: age below 50 years, hemodynamic 
stability, fewer than 4 days in the intensive care 
unit, levels of alanine aminotransferase (ALAT, 
U/L) and aspartate aminotransferase (ASAT, 
U/L) below twice the normal levels, gamma-
glutamyltransferase (GGT) lower than 50 IU/L, 
serum sodium level below 160 mmol/L, and 
less than 20% of fatty infiltration of the liver on 
macroscopic analysis.
 The split technique was performed in 
a standard way, and the arterial trunk and left 
portal branch were dissected in order to remain 
within the graft comprising segments II and III. 
When visible, vascular and biliary structures 
within the liver parenchyma were ligated with 
cotton thread and thick gauges vessels were 
reinforced with 4-0 polypropylene sutures 
(Figure 2). 
 
Figure 2 - Transection of the hepatic graft with the 
split technique.
 To observe correctly the hilar plate 
and perform a bile duct section, we injected 
methylene blue solution into the bile duct to 
achieve an adequate and correct visibility of 
the structure. We then dissected and sectioned 
the hilar plate in order to obtain a single bile 
duct hole in the graft with segments II and III, 
as the location for future reconstruction during 
liver transplantation.
 After reperfusion of the liver graft, 
primary hemostasis was performed in the 
open area with sutures, bandages, and 
mono- and bipolar electrocautery. Similarly, 
we performed suture and ligature of possible 
biliary leak points that could potentially lead to 
postoperative leakage. Following instructions 
from the manufacturer, we used pre-moistened 
sponges and applied their yellow side (the side 
which has the active ingredients) on the wound 
surface of the liver graft. 
 We performed sponge compression 
for about 2 minutes with the help of a wet 
compress, in order to obtain a correct fixation 
of the sponge and local hemostasis. Since the 
extension of the open area is greater than 
the surface of the sponge, we used, when 
necessary, more than one sponge and repeated 
the same process (Figure 3).
 
Figure 3 - Fibrinogen sponge application and 
human thrombin in the open area of pediatric liver 
graft with the split technique.
 This study evaluated the demographic 
characteristics of the recipients, use of 
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red blood cell transfusion during split-liver 
transplantation (in mL/kg), reoperation due to 
wound bleeding, occurrence of biliary leak in 
the open area and graft, and patient survival at 
30 days.
 The analyzed data are expressed 
as mean, median, standard deviation, and 
percentage. The statistical analysis was 
performed with the help of a professional 
statistician. We used the tests Student’s t, 
chi-square, Fisher’s exact and Mann-Whitney, 
as well as Kaplan-Meier survival curves as 
indicated.
 We performed the statistical analysis 
using the software SPSS, version 2.0, and 
considered p values < 0.05 as significant.
 ■ Results
 As shown in Table 1, both groups were 
comparable and had no significant differences 
in the evaluated parameters.
Table 1 - Demographic characteristics of the study 
population.
Group A 
(n=18)
Without the 
Sponge 
Group B 
(n=17)
With the 
Sponge
p
Age 
(years)
1.5 ± 1,2 1,4 ± 1,8 0.85
Sex M: 7
F: 11
M: 9
F: 8
0.5
Weight 
(kg)
11.13 ± 14.30 10.42 ± 9.7 0.86
Height 
(cm)
68.26 ± 11.06 68.5 ± 13.32 0.95
PELD 
score
19.95 ± 8.91 25.58 ± 13.32 0.08
M. males; F. females; PELD score. Pediatric End-Stage Liver 
Disease score
 Regarding the analyzed parameters 
(Table 2), the median volume of red blood cells 
transfused in Group A was significantly higher 
(73.4 ± 102.38 mL/kg) than that in Group B 
(35.1 ± 41.67 mL/kg; p = 0.048).
 When we analyzed those cases that 
required reoperation due to bleeding in the 
wound area of the liver graft, we observed a 
significantly greater number of these patients 
in Group A (10 patients - 55.5%) than in Group 
B (3 patients - 17.6%; p = 0.035).
 Regarding biliary leak in the wound 
area, there was no statistical difference 
comparing both groups, with Group A rate 
showing a rate of 11.1% and Group B a rate of 
17.6% (p = 0.65).
 At 30 days, patient survival rates were 
75% in Group A and 87.5% in Group B (p = 
0.36), while graft survival rates were 75% and 
81.25%, respectively (p = 0.11).
Table 2 - Results of analyzed parameters. 
Group A 
(n=18)
Without 
Sponge
Group B 
(n=17)
With 
Sponge
p
Red blood 
cells 
transfused 
(ml/Kg)
73.4 ± 102.38 35.1 ± 41.67 0.040
Reoperation 
due to 
bleeding in 
the wound 
area
10 (55%) 3 (17.6%) 0.035
Biliary leak 
in the wound 
area
2 (11.1%) 3 (17.6%) 0.65
 ■ Discussion
 The demographic characteristics of the 
patients in whom the human fibrinogen and 
thrombin sponge was used during split-liver 
transplantation were statistically comparable 
to those in whom the sponge was not used, 
thus comprising two similar and comparable 
groups for the analysis of possible outcomes.
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 Regarding the median volume of 
red blood cells transfused during liver 
transplantation, a greater volume was used in 
Group A (without the sponge) when compared 
with Group B (with the sponge). A similar 
observation has been described in a study 
comparing the use of the human fibrinogen and 
thrombin sponge in adult patients undergoing 
split-liver transplantation, which found a lower 
requirement of blood transfusion in patients 
with the use of the sponge25.
 We observed a significantly higher rate 
of reoperation due to bleeding in the wound 
area in Group A when compared with Group 
B, showing that the sponge can improve 
hemostasis in the open area in pediatric 
patients undergoing split-liver transplantation. 
This finding is corroborated in the literature 
assessing the use of the sponge for hemostasis 
of the bleeding liver area after hepatectomy 
and liver transplantation with the split 
technique and / or living donor1,18,20-24.
 In 2008, a traditional group of pediatric 
transplantation in Belgium published their 
experience with the use of the sponge in four 
children undergoing liver transplantation with 
the liver transection technique (two children 
received the left segment of the liver from a 
living donor and two received a reduced liver 
graft). Although this case series lacked a control 
group, the opinion of the authors was that 
the human fibrinogen and thrombin sponge 
performs optimal and effective hemostasis in 
the open area of the graft. They based their 
conclusion on their observation that only one 
concentrate of red blood cells was used per 
patient during transplantation and that none of 
the patients presented post-surgical bleeding24.
 Mirza et al.1 published a prospective, 
multicenter study analyzing the use of 
the sponge in patients undergoing liver 
transplantation with an ex-situ liver transection 
technique and others undergoing hepatectomy. 
They included 16 patients in the study, of 
whom 13 underwent liver transplantation. The 
authors demonstrated an optimal hemostasis 
of the bleeding area with the use of the sponge 
for up to 3 minutes in 81% of the patients 
studied.
 In the present study, there was no 
significant difference in biliary leak rates in the 
wound area when we compared Groups A and 
B. Biliary leak in liver transplantation is directly 
related to complications in the hepatic artery 
and an important cause of morbidity, with 
rates in the literature ranging from 5 to 10% in 
whole-liver transplantation26-28. In cases of liver 
transplantation with the split technique, these 
rates may increase28,29, reaching about 18.8%, 
as described by Diamond et al.30.
 The use of the human fibrinogen and 
thrombin sponge and its association with 
biliary leak and collection of the wound area 
is still controversial in the literature. Toti et 
al.18 published a retrospective study showing a 
reduction in biliary leak rates in adult patients 
undergoing liver transplantation with the split 
technique and the use in the wound area of 
the human fibrinogen and thrombin sponge 
compared with fibrin glue. The authors found 
a reduction in biliary leak rate from 43.75% 
without the sponge to 6.25% with the sponge. 
In contrast, Mirza et al.1 have shown a 12.5% 
reoperation rate due to biliary leak in the 
open area in pediatric patients undergoing 
liver transplantation, regardless of the use or 
nonuse of the human fibrinogen and thrombin 
sponge.
 Both groups showed comparable 30-
day rates in terms of mortality and graft loss. 
The early survival (at 30 days) was based on the 
sponge absorption, that occurs in this period.
 The present study is limited by its 
retrospective design, although the data were 
prospectively collected in a spreadsheet. An 
important strength of the study was the fact 
that all the transplantations were performed 
by the same team in which all members had 
already completed their learning curves at the 
beginning of the study. 
 Use of fibrinogen and thrombin sponge in pediatric split liver transplantation 
Vicentine FPP et al.
Acta Cir Bras. 2017;32(8):673-679
678
 ■ Conclusion
 The use of the human fibrinogen and 
thrombin sponge, when compared with no use 
of the sponge, required a lower volume of red 
blood cell transfusion during the procedure 
and presented lower reoperation rates due to 
bleeding in the wound area.
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